Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
This grant opportunity aims to support the creation and development of medications to prevent and treat opioid and psychostimulant use disorders, as well as overdoses. It involves two phases through the UG3/UH3 Phase Innovation Awards Cooperative Agreement. The first phase (UG3) lasts for two years, where projects must meet certain milestones to qualify for the second phase (UH3), which provid…
The purpose of this Funding Opportunity Announcement is to support the discovery and development of medications to prevent and treat opioid and/or psychostimulant use disorders and overdose. The UG3/UH3 Phase Innovation Awards Cooperative Agreement involves 2 phases. The UG3 is to support a pr…
Funding Source
Awards & funding
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers